当前位置:首页 - 行情中心 - 羚锐制药(600285) - 财务分析 - 资产负债表

羚锐制药

(600285)

  

流通市值:127.66亿  总市值:127.94亿
流通股本:5.66亿   总股本:5.67亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金452,893,627.32382,843,943.47459,656,290.81532,318,999.37
  交易性金融资产290,866,573.38160,351,444.44325,723,298.2160,539,138.16
  应收票据及应收账款744,437,344.32597,628,317.71704,418,747.32684,679,775.27
  其中:应收票据193,431,857.39167,227,781.99171,567,007.61191,584,477.72
        应收账款551,005,486.93430,400,535.72532,851,739.71493,095,297.55
  应收款项融资162,259,888.09115,708,095.3169,437,318.6788,188,522.39
  预付款项36,062,751.7511,533,941.118,615,493.7117,069,552.61
  其他应收款合计10,823,116.547,100,803.69,914,241.5611,467,291.47
  存货392,614,720.7436,636,298.59407,276,808.11411,853,665.96
  一年内到期的非流动资产453,165,516.66530,300,850.54574,046,406.12539,174,656.56
  其他流动资产23,341,169.9337,784,549.165,017,712.991,293,103.07
  流动资产合计2,566,464,708.692,279,888,243.922,574,106,317.52,346,584,704.86
非流动资产:
  长期股权投资72,662,921.2972,665,686.5972,933,218.2373,006,811.38
  其他权益工具投资102,437,447.91102,369,163.6463,063,372.7964,573,291.34
  其他非流动金融资产123,550,792.15123,550,792.15132,536,787.4130,095,083.18
  固定资产645,117,559.99659,178,148.01682,385,860.98695,815,590.61
  在建工程16,956,126.6616,011,118.866,528,114.674,356,175.98
  使用权资产6,704,450.147,433,260.279,054,122.737,987,016
  无形资产324,716,155.08330,142,118.44337,942,323.7345,644,289.83
  开发支出12,215,386.8913,023,083.279,718,952.647,298,316.49
  商誉482,016,236.04482,016,236.04482,016,236.04482,016,236.04
  长期待摊费用5,124,459.585,512,665.525,007,480.345,713,695.74
  递延所得税资产217,695,279.87198,348,585.87218,784,350.79221,801,691.79
  其他非流动资产1,390,023,312.991,345,367,837.681,161,610,587.071,187,334,566.36
  非流动资产合计3,399,220,128.593,355,618,696.343,181,581,407.383,225,642,764.74
  资产总计5,965,684,837.285,635,506,940.265,755,687,724.885,572,227,469.6
流动负债:
  短期借款274,632,517.83391,654,678.75516,684,265.92456,665,931.3
  应付票据及应付账款102,583,238.397,273,440.1391,771,131.61117,951,607.79
        应付账款102,583,238.397,273,440.1391,771,131.61117,951,607.79
  预收款项455,758.51141,637.97129,12383,523
  合同负债71,876,230.9583,638,642.446,918,741.3253,230,856.57
  应付职工薪酬159,861,530.42159,841,212.95149,257,192.25147,709,582.71
  应交税费135,332,421.0972,608,527.77148,756,735.41129,453,273.22
  其他应付款合计1,428,557,965.171,295,447,297.241,423,103,855.761,457,741,331.64
  其中:应付利息194,399.94194,399.94194,399.94194,399.94
  一年内到期的非流动负债1,809,787.122,585,395.812,837,057.713,267,994.14
  其他流动负债16,115,828.7212,388,619.2314,079,286.6327,845,375.68
  流动负债合计2,191,225,278.112,115,579,452.252,393,537,389.612,393,949,476.05
非流动负债:
  租赁负债4,559,885.924,272,081.455,555,023.124,221,716.45
  递延收益36,938,996.0930,999,849.9729,413,862.6331,098,306.15
  递延所得税负债47,635,244.948,741,371.0943,896,132.4842,649,678.55
  非流动负债合计89,134,126.9184,013,302.5178,865,018.2377,969,701.15
  负债合计2,280,359,405.022,199,592,754.762,472,402,407.842,471,919,177.2
所有者权益(或股东权益):
  实收资本(或股本)567,115,486567,115,486567,115,486567,115,486
  资本公积369,242,641.54367,202,273.31360,585,741.35353,926,304.25
  减:库存股12,575,00012,575,00012,575,00012,575,000
  其他综合收益40,320,806.1240,407,787.82,846,678.634,206,353.22
  盈余公积286,212,015.91286,212,015.91286,252,407.42286,252,407.42
  未分配利润2,398,554,938.62,152,221,315.872,044,014,416.671,867,467,613.43
  归属于母公司股东权益合计3,648,870,888.173,400,583,878.893,248,239,730.073,066,393,164.32
  少数股东权益36,454,544.0935,330,306.6135,045,586.9733,915,128.08
  股东权益合计3,685,325,432.263,435,914,185.53,283,285,317.043,100,308,292.4
  负债和股东权益合计5,965,684,837.285,635,506,940.265,755,687,724.885,572,227,469.6
公告日期2026-04-282026-04-282025-10-302025-08-20
审计意见(境内)标准无保留意见
TOP↑